LEMASTERS CHRISTOPHER C. 4
4 · Mirati Therapeutics, Inc. · Filed Feb 19, 2019
Insider Transaction Report
Form 4
LEMASTERS CHRISTOPHER C.
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2019-02-14$72.06/sh−18,562$1,337,489→ 0 total - Sale
Common Stock
2019-02-14$71.65/sh−41,438$2,968,966→ 18,562 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-02-14−60,000→ 60,000 totalExercise: $6.45Exp: 2026-10-02→ Common Stock (60,000 underlying) - Exercise/Conversion
Common Stock
2019-02-14$6.45/sh+60,000$387,000→ 60,000 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $71.03 to $72.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $72.03 to $72.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.